Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 176

Publication Record

Connections

Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Reis M, Geffel KM, Nowalk MP, DaSilva J, Keong LM, Stark TJ, Barnes JR, Wentworth DE, Brammer L, Burns E, Fry AM, Patel MM, Flannery B
(2022) MMWR Morb Mortal Wkly Rep 71: 365-370
MeSH Terms: Adolescent, Adult, Aged, Child, Child, Preschool, Humans, Infant, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza A virus, Influenza B virus, Influenza Vaccines, Influenza, Human, Middle Aged, Population Surveillance, Seasons, United States, Vaccination, Vaccine Efficacy
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
Lytle KL, Collins SP, Feldstein LR, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Grijalva CG, Khan A, Lindsell CJ, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Womack KN, Patel MM, Self WH, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) Vaccine 39: 5271-5276
MeSH Terms: Adult, Humans, Influenza Vaccines, Influenza, Human, United States, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.
Antoon JW, Hall M, Herndon A, Johnson DP, Brown CM, Browning WL, Florin TA, Howard LM, Grijalva CG, Williams DJ
(2021) J Pediatr 239: 32-38.e5
MeSH Terms: Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Influenza, Human, Intensive Care Units, Pediatric, Length of Stay, Male, Nervous System Diseases, Prevalence, Retrospective Studies, Risk Factors, United States
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Grijalva CG, Feldstein LR, Talbot HK, Aboodi M, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Halasa N, Khan A, Lindsell CJ, Nwosu SK, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Patel MM, Self WH, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) Clin Infect Dis 73: 1459-1468
MeSH Terms: Adolescent, Adult, Aged, Case-Control Studies, Humans, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza B virus, Influenza Vaccines, Influenza, Human, Middle Aged, Seasons, United States, Vaccination, Young Adult
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
Feldstein LR, Ferdinands JM, Self WH, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Clark Files D, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M
(2021) J Infect Dis 224: 2035-2042
MeSH Terms: Bias, Humans, Influenza Vaccines, Influenza, Human, Vaccination, Vaccine Efficacy
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).
Feldstein LR, Self WH, Ferdinands JM, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Files DC, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M, Influenza Vaccine Effectiveness in the Critically Ill (IVY) Investigators and the Pediatric Intensive Care Influenza Vaccine Effectiveness (PICFLU-VE) Investigators
(2021) Clin Infect Dis 72: 1669-1675
MeSH Terms: Bias, Case-Control Studies, Humans, Influenza Vaccines, Influenza, Human, Treatment Outcome, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized With Community-acquired Pneumonia.
Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Grijalva CG
(2021) Clin Infect Dis 73: e4433-e4443
MeSH Terms: Adult, Child, Community-Acquired Infections, Hospitalization, Humans, Infant, Parainfluenza Virus 1, Human, Paramyxoviridae Infections, Pneumonia, Viral, Respiratory Tract Infections
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Social Distancing Measures: Evidence of Interruption of Seasonal Influenza Activity and Early Lessons of the SARS-CoV-2 Pandemic.
Wiese AD, Everson J, Grijalva CG
(2021) Clin Infect Dis 73: e141-e143
MeSH Terms: COVID-19, Humans, Influenza, Human, Pandemics, Physical Distancing, SARS-CoV-2, Seasons
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures.
Sevy AM, Soto C, Bombardi RG, Meiler J, Crowe JE
(2019) BMC Bioinformatics 20: 629
MeSH Terms: Adult, Antibodies, Cohort Studies, Fetal Blood, HIV Infections, High-Throughput Nucleotide Sequencing, Humans, Influenza, Human, Middle Aged, Principal Component Analysis, Vaccination
Added March 21, 2020
0 Communities
2 Members
0 Resources
MeSH Terms
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.
Gilchuk IM, Bangaru S, Gilchuk P, Irving RP, Kose N, Bombardi RG, Thornburg NJ, Creech CB, Edwards KM, Li S, Turner HL, Yu W, Zhu X, Wilson IA, Ward AB, Crowe JE
(2019) Cell Host Microbe 26: 715-728.e8
MeSH Terms: Animals, Antibodies, Heterophile, Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral, Birds, Epitopes, Humans, Influenza A Virus, H7N9 Subtype, Influenza Vaccines, Influenza in Birds, Influenza, Human, Mice, Neuraminidase, Orthomyxoviridae Infections, Pre-Exposure Prophylaxis, Vaccination, Vaccines, Inactivated, Viral Proteins, Virus Release
Added March 31, 2020
0 Communities
1 Members
0 Resources
20 MeSH Terms